marquart & small LLP

110 east 25th street
new york, new york 10028

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 16, 2013

NYS DOS ID#
4431913

County

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC REGISTERED LIMITED LIABILITY PARTNERSHIP

Name History
2013 - MARQUART & SMALL LLP









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • What Steps Should NY Biotech Take in 2018? Share Your View on Dec. 11
    By Ben Fidler - Monday Nov 20, 2017

    Change takes time. Particularly in the life sciences, where a single drug’s journey from idea to market can consist of more than a decade of small, yet critical steps. For New York, then, aspirations to become a region known for its biotech industry are—and always have been—a long game in which every year and bit […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Julius Caesar was much ado over nothing
    By Charles Gross - Friday Jun 23, 2017

    The Public Theater should get down on its knees and thank Breitbart, Fox News, Bank of America and Delta Airlines. Because of them, the Public’s production of Julius Caesar in Central Park, an...

    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • Art Gallery Closures Grow for Small and Midsize Dealers
    By ROBIN POGREBIN - Monday Jun 26, 2017

    Large galleries with multiple locations grab wider audiences, dominate art fairs and focus on trophy works. Closures threaten emerging artists.

    Source: NYT > Home Page
  • Police Officer Found Not Guilty in Off-Duty Shooting of Unarmed Man
    By ASHLEY SOUTHALL - Monday Nov 6, 2017

    Jurors weighed whether Officer Wayne Isaacs had a duty to retreat from a confrontation with Delrawn Small. Defense lawyers said he had the right to defend himself.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed